Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.
Keywords: Multivalvular disease; intervention; transcatheter aortic valve implantation; transcatheter mitral valve repair.
Copyright © 2019, Radcliffe Cardiology.